Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Valvular Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 276 articles: HTML format

Single Articles

May 2024
1. AVIERINOS JF, Tribouilloy C, Bursi F, Grigioni F, et al
   Degenerative mitral regurgitation due to flail leaflet: sex-related differences in presentation, management, and outcomes.
   Eur Heart J. 2024 May 16:ehae265. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. DVIR D, Tchetche D, Leon MB, Genereux P, et al
   Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
   Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al
   Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
   Eur Heart J. 2024 May 15:ehae331. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
   Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
   Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. ZEPPENFELD K, de Riva M
   Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
   Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
   PubMed    
   
   
   April 2024
6. PIBAROT P
   Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
   Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
   PubMed    
   
   
   
7. PIERONI M, Namdar M, Olivotto I, Desnick RJ, et al
   Anderson-Fabry disease management: role of the cardiologist.
   Eur Heart J. 2024;45:1395-1409.
   PubMed     Abstract available
   
   
   
8. KASKI JP, Norrish G, Gimeno Blanes JR, Charron P, et al
   Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
   Eur Heart J. 2024;45:1443-1454.
   PubMed     Abstract available
   
   
   
9. TAHARA N, Fukumoto Y, Tayama E
   Utility of vector flow mapping and [18F]fluorodeoxyglucose-positron emission tomography/computed tomography to assess left ventricular workload in obstructive hypertrophic cardiomyopathy.
   Eur Heart J. 2024;45:1488.
   PubMed    
   
   
   
10. BLEIZIFFER S
    Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
    Eur Heart J. 2024;45:1125-1126.
    PubMed    
    
    
    March 2024
11. FRANK D, Durand E, Lauck S, Muir DF, et al
    A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.
    Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. 
    Correction to: Tricuspid valve disease and cardiac implantable electronic devices.
    Eur Heart J. 2024 Mar 29:ehae221. doi: 10.1093.
    PubMed    
    
    
    
13. BAKAR SN, Ong G, Fam NP
    LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.
    Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093.
    PubMed    
    
    
    
14. 
    Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis.
    Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093.
    PubMed    
    
    
    
15. CREA F
    Mitral, aortic, and tricuspid valve disease: new light shed on mechanisms, risk stratification, and treatment optimization.
    Eur Heart J. 2024;45:857-860.
    PubMed    
    
    
    
16. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
    Great debate: symptomatic moderate aortic stenosis should undergo intervention.
    Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
    PubMed    
    
    
    
17. MARTINSSON A, Rasalingam R, Jeppsson A
    Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
    Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
    PubMed    
    
    
    
18. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    PubMed    
    
    
    
19. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. MEHILLI J
    Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
    Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
    PubMed    
    
    
    
21. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
    Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
    Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. MCGREGOR M, Bews H, Jassal DS
    Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place.
    Eur Heart J. 2024 Mar 4:ehae115. doi: 10.1093.
    PubMed    
    
    
    
23. MAISANO F, Hahn R, Sorajja P, Praz F, et al
    Transcatheter treatment of the tricuspid valve: current status and perspectives.
    Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
24. WU J, Zafar MA, Elefteriades JA
    Decision-making in aortic disease.
    Eur Heart J. 2024;45:633-634.
    PubMed    
    
    
    
25. MESSIKA-ZEITOUN D, Iung B, Baumgartner H
    The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease.
    Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093.
    PubMed    
    
    
    
26. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    PubMed    
    
    
    
27. LUDWIG S, Granada JF
    Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward.
    Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093.
    PubMed    
    
    
    
28. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. CREA F
    The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and drug toxicity.
    Eur Heart J. 2024;45:317-320.
    PubMed    
    
    
    January 2024
30. THORNTON GD, Vassiliou VS, Musa TA, Aziminia N, et al
    Myocardial Scar and Remodelling Predict Long-Term Mortality in Severe Aortic Stenosis Beyond 10 Years.
    Eur Heart J. 2024 Jan 25:ehae067. doi: 10.1093.
    PubMed    
    
    
    
31. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
    Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
    Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. NAKAMURA K, Taniguchi T, Furukawa Y
    Haemolytic anaemia after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093.
    PubMed    
    
    
    
35. LI Z, Zhang H, Lin S
    Functionally bicuspid aortic valve leads to myocardial ischaemia.
    Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
    PubMed    
    
    
    
36. LONG X, Deng S, Liu W, Bu J, et al
    Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study.
    Eur Heart J. 2024;45:233-235.
    PubMed    
    
    
    
37. HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al
    Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
    Eur Heart J. 2024;45:198-210.
    PubMed     Abstract available
    
    
    
38. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
    Severe aortic stenosis: secular trends of incidence and outcomes.
    Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. KADDOURA R, Al-Hijji M
    The evolution of transcatheter valvular interventions: current evidence.
    Eur Heart J. 2024;45:10-14.
    PubMed    
    
    
    December 2023
40. ALLOUBA M, Walsh R, Afify A, Hosny M, et al
    Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:5146-5158.
    PubMed     Abstract available
    
    
    
41. INGLES J, MacArthur DG
    The moral and practical urgency of increasing diversity in genomics.
    Eur Heart J. 2023;44:5157-5159.
    PubMed    
    
    
    
42. ANDREAS M, Burri H, Praz F, Soliman O, et al
    Tricuspid valve disease and cardiac implantable electronic devices.
    Eur Heart J. 2023 Dec 14:ehad783. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    PubMed    
    
    
    
44. GRANI C
    Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:4793-4795.
    PubMed    
    
    
    
45. WANG J, Yang S, Ma X, Zhao K, et al
    Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
    Eur Heart J. 2023;44:4781-4792.
    PubMed     Abstract available
    
    
    November 2023
46. VERGALLO R, Volpe M
    Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients.
    Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093.
    PubMed    
    
    
    
47. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    PubMed    
    
    
    
48. BRAUNWALD E, Saberi S, Abraham TP, Elliott PM, et al
    Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:4622-4633.
    PubMed     Abstract available
    
    
    
49. TOMII D, Praz F, Windecker S
    Guideline directed medical therapy in patients with heart failure undergoing transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
    Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093.
    PubMed    
    
    
    
50. CREA F
    Hot topics in valvular heart disease: tricuspid regurgitation, bicuspid aortic valve, artificial intelligence for aortic stenosis, and aortic aneurysm.
    Eur Heart J. 2023;44:4493-4496.
    PubMed    
    
    
    
51. PATEL KP, Baumbach A
    Timing treatment for tricuspid regurgitation.
    Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093.
    PubMed    
    
    
    
52. WERT L, Falk V, Potapov EV
    Severe aortic regurgitation after short-term treatment with microaxial left ventricular assist device in the transaxillary approach.
    Eur Heart J. 2023 Nov 9:ehad750. doi: 10.1093.
    PubMed    
    
    
    
53. IDHREES M, Kumar A, Velayudhan B
    'Paravalvular leak' after Bentall's procedure, yet not a paravalvular leak.
    Eur Heart J. 2023;44:4392.
    PubMed    
    
    
    
54. KODALI S, Hahn RT, Makkar R, Makar M, et al
    Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
    Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
55. HARARI E, Landes U
    Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple aetiologies and no panacea.
    Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093.
    PubMed    
    
    
    
56. KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al
    Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement.
    Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093.
    PubMed    
    
    
    
57. DE BACKER J, Prakash SK
    Refining the course: long-term outcome in patients with bicuspid aortic valve.
    Eur Heart J. 2023 Oct 4:ehad621. doi: 10.1093.
    PubMed    
    
    
    
58. FARJAT-PASOS JI, Dumont E, Paradis JM
    Optimizing transcatheter mitral valve replacement with direct, continuous transvalvular haemodynamic evaluation: first-in-man.
    Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093.
    PubMed    
    
    
    
59. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
    Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
    Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. WEISSLER-SNIR A, Rakowski H, Meyer M
    Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?
    Eur Heart J. 2023;44:3655-3657.
    PubMed    
    
    
    
61. DEVRIES JH, Irs A, Hillege HL
    The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.
    Eur Heart J. 2023;44:3492-3494.
    PubMed    
    
    
    September 2023
62. CHHABRA ST, Takkar A, Arya RC
    An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'.
    Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093.
    PubMed    
    
    
    
63. BEYGUI F, Guillemot V, Saloux E
    Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
    Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
    PubMed    
    
    
    
64. MOORE JP, Aboulhosn JA, Khairy P
    Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot.
    Eur Heart J. 2023;44:3228-3230.
    PubMed    
    
    
    
65. CREA F
    TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
    Eur Heart J. 2023;44:3105-3109.
    PubMed    
    
    
    
66. FENG S, Wu F, Pan X
    Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair.
    Eur Heart J. 2023;44:3199.
    PubMed    
    
    
    August 2023
67. VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al
    Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
    Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al
    TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.
    Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. YANG LT, Ye Z, Wajih Ullah M, Maleszewski JJ, et al
    Bicuspid aortic valve: long-term morbidity and mortality.
    Eur Heart J. 2023 Aug 23:ehad477. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. HOLSTE G, Oikonomou EK, Mortazavi BJ, Coppi A, et al
    Severe aortic stenosis detection by deep learning applied to echocardiography.
    Eur Heart J. 2023 Aug 23:ehad456. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. VAN DISSEL AC, Opotowsky AR, Burchill LJ, Aboulhosn J, et al
    End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study.
    Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. PRENDERGAST BD, Patterson T, Redwood S
    Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
    Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
    PubMed    
    
    
    
73. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
    Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
    Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. AL ZAIDI M, Nickenig G, Zimmer S
    Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
    Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
    PubMed    
    
    
    
75. EIROS R, Gallego-Delgado M, Villacorta E
    Unravelling an hypertrophic myocardiopathy.
    Eur Heart J. 2023;44:2788.
    PubMed    
    
    
    July 2023
76. IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al
    Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement.
    Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093.
    PubMed    
    
    
    
77. WALDSCHMIDT L, Seiffert M
    Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?
    Eur Heart J. 2023 Jul 5:ehad277. doi: 10.1093.
    PubMed    
    
    
    
78. GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al
    Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
    Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. LORENZATTI D, Pina P, Slipczuk L
    Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis dysfunction: the thin line between hypo attenuated leaflet thickening and clinical valve thrombosis.
    Eur Heart J. 2023;44:2350.
    PubMed    
    
    
    June 2023
80. NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al
    Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
    Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. GOEL K, Shah P, Jones BM, Korngold E, et al
    Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. 
    Corrigendum to: MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Jun 21:ehad407. doi: 10.1093.
    PubMed    
    
    
    
83. TAKANO R, Tsuji A, Ogo T
    A beaded ductus arteriosus aneurysm in tetralogy of Fallot with pulmonary atresia after palliative surgery.
    Eur Heart J. 2023 Jun 17:ehad402. doi: 10.1093.
    PubMed    
    
    
    
84. PEDICINO D, Vergallo R
    Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial.
    Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093.
    PubMed    
    
    
    
85. BRAY JJH, Freer R, Pitcher A, Kharbanda R, et al
    Family screening for bicuspid aortic valve and aortic dilatation: a meta-analysis.
    Eur Heart J. 2023 Jun 8:ehad320. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. EVANGELISTA A, Michelena HI
    Family screening for bicuspid aortic valve: indicated, but easy to implement?
    Eur Heart J. 2023 Jun 8:ehad057. doi: 10.1093.
    PubMed    
    
    
    
87. CREA F
    Understanding aortic stenosis: advances in the identification of actionable pharmacological targets.
    Eur Heart J. 2023;44:1847-1850.
    PubMed    
    
    
    May 2023
88. LORENZINI M, Elliott PM
    Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
    Eur Heart J. 2023;44:1519-1521.
    PubMed    
    
    
    
89. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
    Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
    Eur Heart J. 2023;44:1530-1540.
    PubMed     Abstract available
    
    
    April 2023
90. BUTCHER SC, Essayagh B, Enriquez-Sarano M
    Rescue surgery for degenerative mitral regurgitation should be recognized for what it is: indispensable but imperfect.
    Eur Heart J. 2023 Apr 28:ehad242. doi: 10.1093.
    PubMed    
    
    
    
91. DANDEL M
    Degenerative mitral regurgitation: improving clinical decision-making and risk stratification before valve surgery or trans-catheter repair.
    Eur Heart J. 2023 Apr 28:ehad216. doi: 10.1093.
    PubMed    
    
    
    
92. LI Y, He Q, Xie M
    A rare case of papillary muscle rupture caused by percutaneous balloon mitral valvuloplasty.
    Eur Heart J. 2023 Apr 26:ehad254. doi: 10.1093.
    PubMed    
    
    
    
93. LEE J, Kim JS, Shim CY
    MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
    PubMed    
    
    
    
94. PEDICINO D, Vergallo R
    Transcatheter repair for severe tricuspid regurgitation: are we going in the right direction?
    Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093.
    PubMed    
    
    
    
95. ORRINGER CE
    C-reactive protein in people with high lipoprotein a: a partner in crime or an innocent bystander?
    Eur Heart J. 2023;44:1461-1463.
    PubMed    
    
    
    
96. THERIAULT S, Mathieu P, Bosse Y
    The journey towards identification of actionable molecular pathways in calcific aortic valve stenosis.
    Eur Heart J. 2023 Apr 12:ehad134. doi: 10.1093.
    PubMed    
    
    
    
97. CHEN HY, Dina C, Small AM, Shaffer CM, et al
    Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study.
    Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. SEQUEIRA V, Batzner A, Maack C
    Targeting mitochondria in hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:1186-1188.
    PubMed    
    
    
    
99. NOLLET EE, Duursma I, Rozenbaum A, Eggelbusch M, et al
    Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration.
    Eur Heart J. 2023;44:1170-1185.
    PubMed     Abstract available
    
    
    March 2023
100. KAGASE A, Yamamoto M, Tokuda T
     Successful bailout clipping for rare complication of anterior mitral leaflet dissection during transcatheter edge-to-edge mitral valve repair.
     Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093.
     PubMed    
     
     
     
101. XIE Z, Zhu H
     A rare case of mitral regurgitation caused by primary aldosteronism.
     Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093.
     PubMed    
     
     
     
102. CHEN YH, Chang HH, Leu HB
     Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration.
     Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093.
     PubMed    
     
     
     
103. MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al
     Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
     Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. CHORIN E, Topilsky Y
     The synergy between tricuspid regurgitation and machine learning.
     Eur Heart J. 2023 Mar 17:ehad140. doi: 10.1093.
     PubMed    
     
     
     
105. RAO VN, Giczewska A, Chiswell K, Felker GM, et al
     Long-term outcomes of phenoclusters in severe tricuspid regurgitation.
     Eur Heart J. 2023 Mar 16:ehad133. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. MESSIKA-ZEITOUN D, Baumgartner H, Burwash IG, Vahanian A, et al
     Unmet needs in valvular heart disease.
     Eur Heart J. 2023 Mar 16:ehad121. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. CHUNG CJ, Otto CM
     Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation.
     Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093.
     PubMed    
     
     
     
108. LANDES U, Hochstadt A, Manevich L, Webb JG, et al
     Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications.
     Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. CREA F
     Spotlight on aortic stenosis and dissection: mechanisms, management, and new therapeutic targets.
     Eur Heart J. 2023;44:783-787.
     PubMed    
     
     
     
110. RODES-CABAU J, Nuche J
     Are contemporary TAVI results influenced by hospital volume?
     Eur Heart J. 2023;44:868-870.
     PubMed    
     
     
     
111. CHEN J, Yang Y, Wei L
     One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation.
     Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093.
     PubMed    
     
     
     
112. KEMALOGLU OZ T, Badano LP
     Can three-dimensional echocardiography change the game for the pulmonary valve?
     Eur Heart J. 2023;44:703-705.
     PubMed    
     
     
     February 2023
113. THOMAS PE, Vedel-Krogh S, Kamstrup PR, Nordestgaard BG, et al
     Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein.
     Eur Heart J. 2023 Feb 21:ehad055. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. CHEN CB, Jarrett H, Goldman SM
     Candida endocarditis in a transcatheter aortic valve.
     Eur Heart J. 2023 Feb 13:ehad070. doi: 10.1093.
     PubMed    
     
     
     
115. IUNG B, Suc G
     Advances in risk stratification of asymptomatic mitral regurgitation. The quest for optimal timing of surgery continues.
     Eur Heart J. 2023 Feb 8:ehad040. doi: 10.1093.
     PubMed    
     
     
     January 2023
116. 
     Corrigendum to: Dual versus single antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis.
     Eur Heart J. 2023 Jan 31:ehad047. doi: 10.1093.
     PubMed    
     
     
     
117. ZHANG T, Yang X, Song J, Shi Y, et al
     Emergent transcatheter aortic valve implantation combined with enterectomy for acute decompensated heart failure caused by severe aortic stenosis and strangulated femoral hernia.
     Eur Heart J. 2023 Jan 26:ehad007. doi: 10.1093.
     PubMed    
     
     
     
118. BUTCHER SC, Essayagh B, Steyerberg EW, Benfari G, et al
     Factors influencing post-surgical survival in degenerative mitral regurgitation.
     Eur Heart J. 2023 Jan 26:ehad004. doi: 10.1093.
     PubMed     Abstract available
     
     
     
119. MARTIN M, Motta SE, Emmert MY
     Have we found the missing link between inflammation, fibrosis, and calcification in calcific aortic valve disease?
     Eur Heart J. 2023 Jan 23:ehac787. doi: 10.1093.
     PubMed    
     
     
     
120. GABRA B, Anavekar NS, Haaf P
     Hypertrophic cardiomyopathy and left ventricular non-compaction cardiomyopathy: two in one.
     Eur Heart J. 2023;44:327.
     PubMed    
     
     
     
121. IQBAL F, Schlotter F, Becker-Greene D, Lupieri A, et al
     Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity.
     Eur Heart J. 2023 Jan 20:ehac818. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. AHMAD Y, Howard JP, Arnold AD, Madhavan MV, et al
     Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials.
     Eur Heart J. 2023 Jan 20:ehac642. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. PILGRIM T, Siontis GCM, Windecker S
     Transcatheter aortic valve implantation: a blueprint for evidence-based evaluation of technological innovation.
     Eur Heart J. 2023 Jan 20:ehac635. doi: 10.1093.
     PubMed    
     
     
     
124. LEE G, Chikwe J, Milojevic M, Wijeysundera HC, et al
     ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis.
     Eur Heart J. 2023 Jan 12:ehac803. doi: 10.1093.
     PubMed     Abstract available
     
     
     
125. MIYOSHI T, Izutani H, Yamaguchi O
     Pathologic findings of aortic valve leaflet injury via IMPELLA insertion.
     Eur Heart J. 2023 Jan 12:ehac806. doi: 10.1093.
     PubMed    
     
     
     
126. CHIETERA F, Saia F, Palmerini T
     Post-traumatic acute aortic regurgitation due to cusp rupture in non-calcific bicuspid valve treated with ballon-expandable transcatheter heart valve.
     Eur Heart J. 2023 Jan 12:ehac805. doi: 10.1093.
     PubMed    
     
     
     
127. KAISER Y, Labrecque J, Stroes ESG, Boekholdt SM, et al
     Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias? Reply.
     Eur Heart J. 2023 Jan 4:ehac742. doi: 10.1093.
     PubMed    
     
     
     
128. ENRIQUEZ-SARANO M, Grapsa J
     Valvular heart diseases in women: facts vs. incantations.
     Eur Heart J. 2023 Jan 4:ehac774. doi: 10.1093.
     PubMed    
     
     
     
129. LEVIN MG, Damrauer SM
     Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias?
     Eur Heart J. 2023 Jan 4:ehac638. doi: 10.1093.
     PubMed    
     
     
     
130. BAUMGARTNER H, Iung B, Messika-Zeitoun D
     The year in cardiovascular medicine 2022: the top 10 papers in valvular heart disease.
     Eur Heart J. 2023 Jan 2:ehac777. doi: 10.1093.
     PubMed    
     
     
     December 2022
131. 
     Erratum to: Transfemoral aortic valve implantation: procedural hospital volume and mortality in Germany.
     Eur Heart J. 2022 Dec 22:ehac775. doi: 10.1093.
     PubMed    
     
     
     
132. BESTEHORN K, Bestehorn M, Zahn R, Perings C, et al
     Transfemoral aortic valve implantation: procedural hospital volume and mortality in Germany.
     Eur Heart J. 2022 Dec 2:ehac698. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2022
133. SCOTTI A, Coisne A, Taramasso M, Granada JF, et al
     Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation.
     Eur Heart J. 2022 Nov 29:ehac735. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. HUANG X, Sung SH, Su M, Wang Y, et al
     One stone hits two birds: transcatheter mitral valve edge-to-edge repair for hypertrophic obstructive cardiomyopathy and severe mitral regurgitation.
     Eur Heart J. 2022 Nov 25:ehac677. doi: 10.1093.
     PubMed    
     
     
     
135. GESKE JB, Stephens EH, Dearani JA
     Hypertrophic cardiomyopathy with extreme outflow tract obstruction.
     Eur Heart J. 2022;43:4518.
     PubMed    
     
     
     October 2022
136. MAN JP, Bouma BJ, Schuuring MJ
     Fusion imaging in preoperative planning of mitral valve surgery to prevent injury of the left circumflex artery.
     Eur Heart J. 2022 Oct 22. pii: 6769829. doi: 10.1093.
     PubMed    
     
     
     
137. CREA F
     Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: an emerging therapeutic target.
     Eur Heart J. 2022;43:3815-3818.
     PubMed    
     
     
     September 2022
138. AJMONE MARSAN N, Delgado V, Shah DJ, Pellikka P, et al
     Valvular heart disease: shifting the focus to the myocardium.
     Eur Heart J. 2022 Sep 28. pii: 6724464. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. TEN BERG J, Rocca B, Angiolillo DJ, Hayashida K, et al
     The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties.
     Eur Heart J. 2022 Sep 21. pii: 6708420. doi: 10.1093.
     PubMed     Abstract available
     
     
     
140. XIA J, Xue Y, Ma X
     A rare case of native aortic valve thrombosis after radiofrequency ablation.
     Eur Heart J. 2022 Sep 16. pii: 6701788. doi: 10.1093.
     PubMed    
     
     
     
141. HAN Y
     Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement.
     Eur Heart J. 2022 Sep 14. pii: 6697004. doi: 10.1093.
     PubMed    
     
     
     August 2022
142. KRONENBERG F, Mora S, Stroes ESG, Ference BA, et al
     Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
     Eur Heart J. 2022 Aug 29. pii: 6670882. doi: 10.1093.
     PubMed     Abstract available
     
     
     
143. ZHANG X, Wang H, Guo Y, Peng Y, et al
     Aortic root 'sink down' caused mitral stenosis after aortic valve replacement: a rare presentation of Bechet's disease.
     Eur Heart J. 2022 Aug 18. pii: 6670978. doi: 10.1093.
     PubMed    
     
     
     
144. KRONENBERG F
     Lipoprotein(a) and aortic valve stenosis: work in progress.
     Eur Heart J. 2022 Aug 18. pii: 6670979. doi: 10.1093.
     PubMed    
     
     
     
145. WENZEL P
     Thromboinflammation in cardiovascular disease: lessons learned for the management of hypertension, heart failure, and aortic valve stenosis.
     Eur Heart J. 2022 Aug 18. pii: 6671020. doi: 10.1093.
     PubMed    
     
     
     
146. 
     Corrigendum to: Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
     Eur Heart J. 2022 Aug 3. pii: 6653544. doi: 10.1093.
     PubMed    
     
     
     
147. CREA F
     Challenges in the management of aortic stenosis, multiple valve disease, culture-negative endocarditis, and cardiac surgery during pregnancy.
     Eur Heart J. 2022;43:2715-2719.
     PubMed    
     
     
     
148. HAHN RT, Pibarot P, Otto CM
     Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.
     Eur Heart J. 2022;43:2767-2769.
     PubMed    
     
     
     
149. ANDREOTTI F, Massetti M, Ten Berg J
     Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS.
     Eur Heart J. 2022;43:2798-2800.
     PubMed    
     
     
     
150. ZHAO ZG, Chen F, Wei X, Feng Y, et al
     Transcatheter mitral valve implantation in severely calcified rheumatic mitral stenosis without annular calcification.
     Eur Heart J. 2022 Aug 1. pii: 6652910. doi: 10.1093.
     PubMed    
     
     
     July 2022
151. KAISER Y, van der Toorn JE, Singh SS, Zheng KH, et al
     Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification.
     Eur Heart J. 2022 Jul 23. pii: 6649081. doi: 10.1093.
     PubMed     Abstract available
     
     
     
152. PARALE C, Ahmed AS, Bhardwaj A
     Isolated posterior mitral leaflet elongation-related dynamic left ventricular outflow obstruction.
     Eur Heart J. 2022;43:2713.
     PubMed    
     
     
     
153. BHARDWAJ A, Pillai AA, Balaguru S
     A case of hypoplastic posterior mitral leaflet-related severe mitral regurgitation associated with ostium secundum atrial septal defect.
     Eur Heart J. 2022 Jul 21. pii: 6647914. doi: 10.1093.
     PubMed    
     
     
     
154. BAJAJ A, Cuchel M
     From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?
     Eur Heart J. 2022 Jul 13. pii: 6641994. doi: 10.1093.
     PubMed     Abstract available
     
     
     
155. BELANGER AM, Akioyamen LE, Ruel I, Hales L, et al
     Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century.
     Eur Heart J. 2022 Jul 1. pii: 6625868. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2022
156. VERGALLO R, Volpe M
     The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis.
     Eur Heart J. 2022 Jun 25. pii: 6617779. doi: 10.1093.
     PubMed    
     
     
     
157. 
     Corrigendum to: Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
     Eur Heart J. 2022 Jun 18. pii: 6611060. doi: 10.1093.
     PubMed    
     
     
     
158. WEI X, Zhou M, Chen Y, Chen M, et al
     Paroxysmal massive mitral regurgitation.
     Eur Heart J. 2022 Jun 17. pii: 6609956. doi: 10.1093.
     PubMed    
     
     
     
159. HAN Y
     Current clinical data and experience of TAVR in China.
     Eur Heart J. 2022;43:2087-2088.
     PubMed    
     
     
     
160. BELLUSCHI I, Buzzatti N, Denti P, Maisano F, et al
     Transcatheter lithotripsy to facilitate post-dilatation of underexpanded aortic transcatheter heart valve.
     Eur Heart J. 2022;43:2081.
     PubMed    
     
     
     
161. 
     Corrigendum to: Transcatheter repair of persistent tricuspid regurgitation after MitraClip with the TriCinch system: interventional valve treatment toward the surgical standard.
     Eur Heart J. 2022 Jun 1. pii: 6596482. doi: 10.1093.
     PubMed    
     
     
     
162. 
     Corrigendum to: Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation.
     Eur Heart J. 2022 Jun 1. pii: 6596481. doi: 10.1093.
     PubMed    
     
     
     May 2022
163. 
     Corrigendum to: The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
     Eur Heart J. 2022 May 19. pii: 6588540. doi: 10.1093.
     PubMed    
     
     
     
164. COLLET JP, Van Belle E, Thiele H, Berti S, et al
     Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
     Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
     Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
     Eur Heart J. 2022;43:1884.
     PubMed    
     
     
     
166. GALIUTO L, Massetti M
     To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
     Eur Heart J. 2022;43:1792-1793.
     PubMed    
     
     
     
167. WILSON J, Muthumala A, Khanji MY
     Complete resolution of apical hypertrophy and fibrosis: the role of serial cardiovascular magnetic resonance tissue characterization to differentiate hypertrophic cardiomyopathy from myocarditis.
     Eur Heart J. 2022;43:1774.
     PubMed    
     
     
     
168. TRIBOUILLOY C, Bohbot Y, Kubala M, Ruschitzka F, et al
     Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
     Eur Heart J. 2022 May 2. pii: 6576528. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. CREA F
     Valvular heart disease: the quest for new pharmacological targets.
     Eur Heart J. 2022;43:1601-1604.
     PubMed    
     
     
     
170. BEDEIR K, Robichaux RP, Gleason TG
     Surgical whole valve embolization 15 years after implantation.
     Eur Heart J. 2022;43:1685.
     PubMed    
     
     
     
171. JANG SJ, Chen YH, Shen TC
     Pitfalls in recapture or repositioning of Evolut system using cusp overlap technique.
     Eur Heart J. 2022;43:1684.
     PubMed    
     
     
     April 2022
172. WINDECKER S, Okuno T, Unbehaun A, Mack M, et al
     Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
     Eur Heart J. 2022 Apr 25. pii: 6572863. doi: 10.1093.
     PubMed     Abstract available
     
     
     
173. DAYAN V, Gomes WJ
     The new ESC/EACTS recommendations for transcatheter aortic valve implantation go too far.
     Eur Heart J. 2022 Apr 25. pii: 6572861. doi: 10.1093.
     PubMed    
     
     
     
174. THIELE H, Collet JP, Leon M, Mehran R, et al
     The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
     Eur Heart J. 2022 Apr 25. pii: 6572862. doi: 10.1093.
     PubMed    
     
     
     
175. CALCAGNO S, Di Pietro R, Biondi-Zoccai G, Versaci F, et al
     Cerebral protection device out of transcatheter heart procedures: a bridge to surgery.
     Eur Heart J. 2022;43:1598.
     PubMed    
     
     
     
176. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
     Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
     Eur Heart J. 2022;43:1599.
     PubMed    
     
     
     March 2022
177. GALIUTO L, Massetti M
     To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
     Eur Heart J. 2022 Mar 10. pii: 6546148. doi: 10.1093.
     PubMed    
     
     
     
178. TRENKWALDER T, Krane M
     Mitral valve prolapse: will genetics finally solve the puzzle?
     Eur Heart J. 2022 Mar 10. pii: 6546010. doi: 10.1093.
     PubMed    
     
     
     
179. ROSELLI C, Yu M, Nauffal V, Georges A, et al
     Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.
     Eur Heart J. 2022 Mar 4. pii: 6542554. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2022
180. KRALER S, Garg V, Akhmedov A
     Calcific aortic valve disease: novel insights into nitric oxide signalling.
     Eur Heart J. 2022 Feb 21. pii: 6533232. doi: 10.1093.
     PubMed    
     
     
     
181. RUDOLPH V
     Heart and kidney: towards an integrated approach to secondary mitral regurgitation.
     Eur Heart J. 2022 Feb 18. pii: 6530471. doi: 10.1093.
     PubMed    
     
     
     
182. 
     Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thorac
     Eur Heart J. 2022 Feb 18. pii: 6533332. doi: 10.1093.
     PubMed    
     
     
     
183. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
     Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
     Eur Heart J. 2022 Feb 16. pii: 6531943. doi: 10.1093.
     PubMed    
     
     
     
184. SCHMIADY MO, Carrel T, Sigler M, Eildermann K, et al
     Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup.
     Eur Heart J. 2022 Feb 15. pii: 6528555. doi: 10.1093.
     PubMed    
     
     
     
185. CREA F
     A comprehensive update on valvular heart disease: from mechanisms to Guidelines.
     Eur Heart J. 2022;43:545-549.
     PubMed    
     
     
     
186. COLOMBO A, Maisano F
     A new tool for the forgotten valve: a score to predict the risk of surgery.
     Eur Heart J. 2022;43:663-665.
     PubMed    
     
     
     
187. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
     Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
     Eur Heart J. 2022;43:666-679.
     PubMed     Abstract available
     
     
     
188. PAUL JF, Lansac E, Chambon E, Neuvillers L, et al
     Aortic jet lesion: new insights with multimodal imaging.
     Eur Heart J. 2022;43:543.
     PubMed    
     
     
     
189. LIU Z, Dong N, Hui H, Wang Y, et al
     Endothelial cell-derived tetrahydrobiopterin prevents aortic valve calcification.
     Eur Heart J. 2022 Feb 9. pii: 6525632. doi: 10.1093.
     PubMed     Abstract available
     
     
     
190. IUNG B, Urena M
     New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly?
     Eur Heart J. 2022;0.
     PubMed    
     
     
     
191. BEOHAR N, Ailawadi G, Kotinkaduwa LN, Redfors B, et al
     Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.
     Eur Heart J. 2022 Feb 3. pii: 6521532. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
192. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
     Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
     Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
     PubMed     Abstract available
     
     
     
193. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
     Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
     Eur Heart J. 2022 Jan 28. pii: 6516865. doi: 10.1093.
     PubMed    
     
     
     
194. VOLPE M, Liuzzo G
     VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?
     Eur Heart J. 2022;43:181-182.
     PubMed    
     
     
     
195. BAUMGARTNER H, Iung B, Messika-Zeitoun D, Otto CM, et al
     The year in cardiovascular medicine 2021: valvular heart disease.
     Eur Heart J. 2022 Jan 3. pii: 6491394. doi: 10.1093.
     PubMed    
     
     
     December 2021
196. WEERASEKARE JM, Geske JB
     'Heart within a heart': echocardiographic assessment of hypertrophic cardiomyopathy.
     Eur Heart J. 2021;42:4775.
     PubMed    
     
     
     November 2021
197. BAUMGARTNER H
     Aortic stenosis management in 2021: better teaming up than fighting between specialties.
     Eur Heart J. 2021 Nov 28. pii: 6445126. doi: 10.1093.
     PubMed    
     
     
     
198. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
     Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
     Eur Heart J. 2021 Nov 25. pii: 6439994. doi: 10.1093.
     PubMed     Abstract available
     
     
     
199. KRALER S, Blaser MC, Aikawa E, Camici GG, et al
     Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.
     Eur Heart J. 2021 Nov 25. pii: 6440005. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2021
200. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
     Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
     Eur Heart J. 2021;42:3932-3944.
     PubMed     Abstract available
     
     
     
201. ELLIOTT P
     Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.
     Eur Heart J. 2021;42:3945-3947.
     PubMed    
     
     
     September 2021
202. DREYFUS J, Audureau E, Bohbot Y, Coisne A, et al
     TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.
     Eur Heart J. 2021 Sep 29. pii: 6377884. doi: 10.1093.
     PubMed     Abstract available
     
     
     
203. CHEN QQ, Ma G, Liu JF, Cai YY, et al
     Neuraminidase 1 is a driver of experimental cardiac hypertrophy.
     Eur Heart J. 2021;42:3770-3782.
     PubMed     Abstract available
     
     
     
204. RAMAKUMAR V, Gupta A, Goswami KC, Jagia P, et al
     Mitral valvular nodules of acute rheumatic fever masquerading as intracardiac mass.
     Eur Heart J. 2021 Sep 16. pii: 6371300. doi: 10.1093.
     PubMed    
     
     
     
205. VAHANIAN A, Praz F, Milojevic M, Beyersdorf F, et al
     The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease.
     Eur Heart J. 2021 Sep 16. pii: 6371303. doi: 10.1093.
     PubMed    
     
     
     
206. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
     Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
     Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
     PubMed     Abstract available
     
     
     
207. MESSIKA-ZEITOUN D, Hibbert B, Chan V
     'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
     Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
     PubMed    
     
     
     August 2021
208. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
     Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
     Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
     PubMed     Abstract available
     
     
     
209. VAHANIAN A, Beyersdorf F, Praz F, Milojevic M, et al
     2021 ESC/EACTS Guidelines for the management of valvular heart disease.
     Eur Heart J. 2021 Aug 28. pii: 6358470. doi: 10.1093.
     PubMed    
     
     
     
210. LOPES LR, Garcia-Hernandez S, Lorenzini M, Futema M, et al
     Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
     Eur Heart J. 2021;42:3063-3073.
     PubMed     Abstract available
     
     
     
211. WALSH R, Bezzina CR
     ALPK3: a full spectrum cardiomyopathy gene?
     Eur Heart J. 2021;42:3074-3077.
     PubMed    
     
     
     
212. LAURI FM, Fernandez-Golfin C, Zamorano JL, Sanchez-Recalde A, et al
     Coronary compression caused by extrinsic adventitial damage: case of an early complication of trans-catheter tricuspid annuloplasty with cardioband device.
     Eur Heart J. 2021 Aug 18. pii: 6354189. doi: 10.1093.
     PubMed    
     
     
     
213. BRAUNWALD E
     Reflections on Hypertrophic Cardiomyopathy.
     Eur Heart J. 2021;42:2969-2970.
     PubMed    
     
     
     
214. TEN BERG J
     Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation.
     Eur Heart J. 2021 Aug 9. pii: 6346754. doi: 10.1093.
     PubMed    
     
     
     
215. DANGAS G, Nicolas J, Mehran R
     Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data.
     Eur Heart J. 2021 Aug 9. pii: 6346755. doi: 10.1093.
     PubMed    
     
     
     
216. CREA F
     The new frontiers in valvular heart disease: from artificial intelligence to new pharmacological targets in aortic stenosis.
     Eur Heart J. 2021;42:2871-2875.
     PubMed    
     
     
     
217. GHAREBAGHI N, Mehdizade H, Askari B, Mirza-Aghazadeh-Attari M, et al
     A bizarre foreign object in the heart: toothpick lodged in the tricuspid valve.
     Eur Heart J. 2021;42:2957.
     PubMed    
     
     
     July 2021
218. TAMARGO J, Agewall S
     Fluoroquinolone use and valvular heart disease: is the jury still out?
     Eur Heart J. 2021 Jul 13. pii: 6319851. doi: 10.1093.
     PubMed    
     
     
     
219. STRANGE JE, Holt A, Blanche P, Gislason G, et al
     Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study.
     Eur Heart J. 2021 Jul 10. pii: 6318706. doi: 10.1093.
     PubMed     Abstract available
     
     
     
220. OYETUNJI SO, Otto CM
     Transcatheter aortic valve implantation or replacement? Valve durability in the context of patient life expectancy.
     Eur Heart J. 2021 Jul 1. pii: 6311995. doi: 10.1093.
     PubMed    
     
     
     June 2021
221. ROGERS MA, Aikawa E
     Unbiased omics identifies mechanistic regulators of calcific aortic valve disease.
     Eur Heart J. 2021 Jun 28. pii: 6310290. doi: 10.1093.
     PubMed    
     
     
     
222. JORGENSEN TH, Thyregod HGH, Ihlemann N, Nissen H, et al
     Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.
     Eur Heart J. 2021 Jun 28. pii: 6310288. doi: 10.1093.
     PubMed     Abstract available
     
     
     
223. WANG Y, Han D, Zhou T, Chen C, et al
     DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells.
     Eur Heart J. 2021 Jun 28. pii: 6310285. doi: 10.1093.
     PubMed     Abstract available
     
     
     
224. XIE Y, Fang L, Li H, Xie M, et al
     Multimodality cardiac imaging for guidance of transapical transcatheter aortic valve implantation and mitral paravalvular leak closure.
     Eur Heart J. 2021 Jun 25. pii: 6309732. doi: 10.1093.
     PubMed    
     
     
     
225. MALAGOLI A, Chiusolo S, Tondi S
     Isolated double-orifice mitral valve: an atypical morphology in adult patient.
     Eur Heart J. 2021 Jun 21. pii: 6307143. doi: 10.1093.
     PubMed    
     
     
     
226. GOLIASCH G, Lang IM
     Impact of sex on the management and outcome of aortic stenosis patients: a female aortic valve stenosis paradox, and a call for personalized treatments?
     Eur Heart J. 2021 Jun 13. pii: 6297824. doi: 10.1093.
     PubMed    
     
     
     
227. VINNAKOTA S, Jentzer JC, Luis SA
     Thrombolysis for COVID-19-associated bioprosthetic mitral valve thrombosis with shock.
     Eur Heart J. 2021 Jun 11. pii: 6296967. doi: 10.1093.
     PubMed    
     
     
     
228. CREA F
     Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
     Eur Heart J. 2021;42:2137-2140.
     PubMed    
     
     
     May 2021
229. BIENJONETTI-BOUDREAU D, Fleury MA, Voisine M, Paquin A, et al
     Impact of sex on the management and outcome of aortic stenosis patients.
     Eur Heart J. 2021 May 23. pii: 6282426. doi: 10.1093.
     PubMed     Abstract available
     
     
     
230. KASKI JP
     Childhood-onset hypertrophic cardiomyopathy research coming of age.
     Eur Heart J. 2021;42:1997-1999.
     PubMed    
     
     
     
231. MARSTON NA, Han L, Olivotto I, Day SM, et al
     Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
     Eur Heart J. 2021;42:1988-1996.
     PubMed     Abstract available
     
     
     
232. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
     A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
     Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
     PubMed     Abstract available
     
     
     
233. CALIGIURI G, Franck G
     Hitting the right channels to spread a 'no-restenosis' message to vascular wall cells.
     Eur Heart J. 2021;42:1786-1788.
     PubMed    
     
     
     April 2021
234. GENEREUX P, Piazza N, Alu MC, Nazif T, et al
     Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.
     Eur Heart J. 2021 Apr 19. pii: 6237954. doi: 10.1093.
     PubMed     Abstract available
     
     
     
235. TEN BERG J, Sibbing D, Rocca B, Van Belle E, et al
     Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in coll
     Eur Heart J. 2021 Apr 5. pii: 6210683. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2021
236. CREA F
     Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation.
     Eur Heart J. 2021;42:1185-1189.
     PubMed    
     
     
     
237. COHEN-SHELLY M, Attia ZI, Friedman PA, Ito S, et al
     Electrocardiogram screening for aortic valve stenosis using artificial intelligence.
     Eur Heart J. 2021 Mar 22. pii: 6179522. doi: 10.1093.
     PubMed     Abstract available
     
     
     
238. COATS AJS, Anker SD, Baumbach A, Alfieri O, et al
     The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and
     Eur Heart J. 2021 Mar 18. pii: 6174642. doi: 10.1093.
     PubMed     Abstract available
     
     
     
239. DIBIE A, Landolff Q, Veugeois A, Amabile N, et al
     Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion.
     Eur Heart J. 2021;42:1051.
     PubMed    
     
     
     February 2021
240. CASE BC, Ben-Dor I, Satler LF, Waksman R, et al
     Rescue alcohol septal ablation for dynamic left ventricular outflow tract obstruction and haemodynamic collapse after transcatheter aortic valve implantation.
     Eur Heart J. 2021 Feb 21. pii: 6145857. doi: 10.1093.
     PubMed    
     
     
     
241. CREA F
     New guidelines on adult congenital heart disease, the fantastic four in the treatment of heart failure, and also what happened in the last year in heart failure and valvular heart disease.
     Eur Heart J. 2021;42:551-554.
     PubMed    
     
     
     
242. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
     Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
     Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2021
243. KRONENBERG F
     Aortic valve stenosis: the long and winding road.
     Eur Heart J. 2021 Jan 31. pii: 6124840. doi: 10.1093/eurheartj/ehaa1069.
     PubMed    
     
     
     
244. QUERCIOLI A, Capettini AC, Gherli R, Secco GG, et al
     Three-dimensional echo guidance of percutaneous mitral paravalvular leak closure.
     Eur Heart J. 2021;42:359.
     PubMed    
     
     
     
245. GOPALAMURUGAN AB, Anantharaman R, Abubacker M, Varshaa GM, et al
     First-in-man proof of feasibility: PCI, TAVR, and TEVAR of aortic arch with a hybrid approach through a trans-caval (cavo-aortic) access in the same procedure.
     Eur Heart J. 2021;42:357.
     PubMed    
     
     
     
246. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
     Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
     Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
     PubMed     Abstract available
     
     
     
247. GALIUTO L, Patrono C
     Rivaroxaban, a novel option for patients with atrial fibrillation and a bioprosthetic mitral valve.
     Eur Heart J. 2021 Jan 4. pii: 6062729. doi: 10.1093/eurheartj/ehaa1075.
     PubMed    
     
     
     
248. BERMEJO J, Postigo A, Baumgartner H
     The year in cardiovascular medicine 2020: valvular heart disease.
     Eur Heart J. 2021 Jan 3. pii: 6060050. doi: 10.1093/eurheartj/ehaa1060.
     PubMed    
     
     
     
249. NICHOLLS M
     The Year in Cardiovascular Medicine 2020: Valvular Heart Disease.
     Eur Heart J. 2021 Jan 3. pii: 6060073. doi: 10.1093/eurheartj/ehaa1024.
     PubMed    
     
     
     December 2020
250. QIAN H, Li Y, Qin Y, Huang H, et al
     An unusual left ventricle pseudo-aneurysm with progressive mitral regurgitation.
     Eur Heart J. 2020 Dec 31. pii: 6056658. doi: 10.1093/eurheartj/ehaa1076.
     PubMed    
     
     
     
251. CHEN J, Wei L, Wang C
     The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery.
     Eur Heart J. 2020 Dec 12. pii: 6031686. doi: 10.1093.
     PubMed    
     
     
     
252. VERMEERSCH G, Prihadi E, De Keulenaer G, Vermeersch P, et al
     Giant native aortic valve thrombus under non-vitamin K antagonist oral anticoagulant: first manifestation of antiphospholipid syndrome.
     Eur Heart J. 2020 Dec 11. pii: 6030876. doi: 10.1093.
     PubMed    
     
     
     
253. AKAZAWA Y, Higaki T, Moritani T, Yamaguchi O, et al
     Acute mitral valve occlusion caused by atrial septal defect occluder.
     Eur Heart J. 2020 Dec 11. pii: 6031437. doi: 10.1093.
     PubMed    
     
     
     
254. CREA F
     Challenges in risk stratification of symptomatic and asymptomatic valvular heart disease: lessons from large observational studies.
     Eur Heart J. 2020;41:4289-4292.
     PubMed    
     
     
     
255. TOTH E, Dancy L, Amin-Youssef G, Papachristidis A, et al
     Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient.
     Eur Heart J. 2020;41:4365.
     PubMed    
     
     
     November 2020
256. HAHN RT
     Degenerative mitral stenosis: interpreting the meaning of mean gradient.
     Eur Heart J. 2020 Nov 30. pii: 6010480. doi: 10.1093.
     PubMed    
     
     
     
257. BERTRAND PB, Churchill TW, Yucel E, Namasivayam M, et al
     Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction.
     Eur Heart J. 2020 Nov 22. pii: 5998318. doi: 10.1093.
     PubMed     Abstract available
     
     
     
258. SONG L, Jin J, Ma X, Xu M, et al
     Aortic dissection and rupture in a 3-year-old boy with bicuspid aortic valve.
     Eur Heart J. 2020 Nov 17. pii: 5986680. doi: 10.1093.
     PubMed    
     
     
     
259. REID A, Blanke P, Bax JJ, Leipsic J, et al
     Multimodality imaging in valvular heart disease: how to use state-of-the-art technology in daily practice.
     Eur Heart J. 2020 Nov 13. pii: 5981494. doi: 10.1093.
     PubMed     Abstract available
     
     
     
260. WATANABE M, Miyachi H, Uchiyama S, Shimizu W, et al
     Thickening of the sinus of Valsalva wall and aortic valve leaflet in a case of Takayasu's arteritis.
     Eur Heart J. 2020 Nov 12. pii: 5979511. doi: 10.1093.
     PubMed    
     
     
     
261. ALIZADEHASL A, Salehi P, Roudbari S, Peighambari MM, et al
     Infectious endocarditis of the prosthetic mitral valve after COVID-19 infection.
     Eur Heart J. 2020 Nov 7. pii: 5960182. doi: 10.1093.
     PubMed    
     
     
     
262. GALIUTO L, Patrono C
     New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trial.
     Eur Heart J. 2020;41:4089-4090.
     PubMed    
     
     
     
263. SHARMA A, Bertog S, Mbai M
     Transcatheter aortic valve lithotripsy in severely calcified bicuspid aortic stenosis prior to transcatheter aortic valve implantation.
     Eur Heart J. 2020 Nov 6. pii: 5959818. doi: 10.1093.
     PubMed    
     
     
     October 2020
264. IDRIS A, Smith Ii RL, Ryan WH, Wang Z, et al
     Primary malignant fibrous histiocytoma of the mitral valve as a rare incidental finding.
     Eur Heart J. 2020 Oct 17. pii: 5927542. doi: 10.1093.
     PubMed    
     
     
     
265. SWEDA R, Berger D, Heverhagen JT, Hunziker L, et al
     Pulmonary haemorrhage on veno-arterial ECMO: consequences of missed aortic valve regurgitation.
     Eur Heart J. 2020 Oct 14. pii: 5922864. doi: 10.1093.
     PubMed    
     
     
     September 2020
266. DELGADO V, Ajmone Marsan N, Bax JJ
     The difficult decision of when and in whom to perform isolated tricuspid valve surgery.
     Eur Heart J. 2020 Sep 27. pii: 5912178. doi: 10.1093.
     PubMed    
     
     
     
267. VALLABHAJOSYULA S, Said SM, Kitzmann AS, Michelena HI, et al
     Accelerated extensive mitral valve calcification in a young end-stage kidney disease patient.
     Eur Heart J. 2020 Sep 27. pii: 5912177. doi: 10.1093.
     PubMed    
     
     
     
268. GARBI M, Lancellotti P
     Heart Valve Specialist Core Syllabus of the ESC Council on Valvular Heart Disease.
     Eur Heart J. 2020 Sep 25. pii: 5911420. doi: 10.1093.
     PubMed    
     
     
     
269. DREYFUS J, Flagiello M, Bazire B, Eggenspieler F, et al
     Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes.
     Eur Heart J. 2020 Sep 25. pii: 5911419. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2020
270. LUSCHER TF
     Frontiers in valvular heart disease: outcomes of novel percutaneous procedures.
     Eur Heart J. 2020;41:2717-2720.
     PubMed    
     
     
     May 2020
271. LUSCHER TF
     From TAVI to tricuspid cliping: fine-tuning the management of valvular heart disease.
     Eur Heart J. 2020;41:1863-1866.
     PubMed    
     
     
     
272. NAZARZADEH M, Rahimi K
     Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects.
     Eur Heart J. 2020;41:1942.
     PubMed    
     
     
     
273. NICKENIG G, Vogelhuber J
     The tricuspid tragedy: from Cinderella to celebrity.
     Eur Heart J. 2020;41:1930-1931.
     PubMed    
     
     
     
274. WEBB J, Wood D, Sathananthan J, Landes U, et al
     Balloon-expandable or self-expandable transcatheter heart valves. Which are best?
     Eur Heart J. 2020;41:1900-1902.
     PubMed    
     
     
     February 2020
275. JERING KS, Pfeffer MA
     From practice changing to hypothesis generating: a virtuous cycle.
     Eur Heart J. 2020;41:955-957.
     PubMed    
     
     
     
276. LUSCHER TF
     Valvular heart disease: improved procedural success and prediction of outcomes.
     Eur Heart J. 2020;41:899-902.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.